IBIO Company Profile and Key Details

Q: Who are the executives of IBIO?

Dr. Melissa Berquist Ph.D.Vice President and Head of Vaccines & Animal HealthMr. Thomas F. Isett IIIChief Executive Officer, Pres & Executive DirectorMr. Robert Matthew LutzChief Financial & Bus. OfficerMr. Felipe DuranChief Financial OfficerMs. Lisa MiddlebrookChief HR OfficerMr. Randy Joe MadduxStrategic AdvisorMr. Robert B. KayInterim Sec. & Interim TreasurerDr. Nick DeLong Ph.D.Vice President of Corporation Devel.Dr. Martin B. Brenner D.V.M., Ph.D.Interim Chief Executive Officer & Chief Scientific OfficerMike JenkinsVice President of OperationsMr. Marc Banjak J.D.Gen. CounselCarlos PicosseChief Executive Officer of IBio Brazil

NASDAQ : IBIO

iBio

$1.56

0.01+0.65%

At Close 4:00 PM

62.21

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

iBio, Inc. (IBIO) stock surged +0.65%, trading at $1.56 on NASDAQ, up from the previous close of $1.55. The stock opened at $1.56, fluctuating between $1.51 and $1.57 in the recent session.

Stock Snapshot

1.55

Prev. Close

24.63M

Market Cap

1.51

Day Low

-2.79

P/E Ratio

-0.56

EPS (TTM)

-10.34

Cash Flow per Share

1.56

Open

15.79M

Number of Shares

1.57

Day High

94.62%

Free Float in %

4.96

Book Value

699.41K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
May 14, 2026	1.56	1.57	1.51	1.56	699.41K
May 13, 2026	1.62	1.62	1.55	1.55	663.05K
May 12, 2026	1.66	1.67	1.59	1.61	396.23K
May 11, 2026	1.73	1.74	1.63	1.66	662.3K
May 08, 2026	1.64	1.75	1.59	1.71	1.83M
May 07, 2026	1.76	1.79	1.63	1.64	369.82K
May 06, 2026	1.61	1.78	1.60	1.77	1.92M
May 05, 2026	1.61	1.65	1.55	1.61	794.81K
May 04, 2026	1.62	1.65	1.52	1.58	2.15M
Apr 30, 2026	1.60	1.70	1.55	1.69	2.98M
Apr 29, 2026	1.61	1.63	1.52	1.62	926.09K
Apr 28, 2026	1.68	1.74	1.62	1.63	652.8K
Apr 27, 2026	1.68	1.73	1.62	1.71	953.89K
Apr 23, 2026	1.93	1.93	1.74	1.81	1.26M
Apr 22, 2026	1.94	1.96	1.85	1.92	756.91K
Apr 21, 2026	2.00	2.02	1.91	1.92	558.56K
Apr 20, 2026	2.04	2.09	1.91	1.97	882.29K
Apr 17, 2026	2.14	2.19	2.04	2.06	770.59K
Apr 16, 2026	2.12	2.15	2.06	2.11	668.92K
Apr 14, 2026	2.23	2.25	2.18	2.19	452.21K

Contact Details

Bryan, TX 77807

United States

https://www.ibioinc.com 979 446 0027

About Company

iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for the treatment of systemic scleroderma and idiopathic pulmonary fibrosis. The company is also developing vaccine candidates comprising IBIO-200 and IBIO-201, which are in preclinical development for the prevention of severe acute respiratory syndrome coronavirus 2; and IBIO-400 for the treatment of classical swine fever. In addition, it is developing recombinant proteins for third parties on a catalog and custom basis; and offers a range of process development, manufacturing, filling and finishing, and bio analytic services. iBio, Inc. has a license agreement with Planet Biotechnology, Inc. to develop therapeutics for infectious diseases; collaboration agreement with The Texas A&M University System for the development of coronavirus disease 2019 vaccine candidates; license agreement with the University of Natural Resources and Life Sciences, Vienna; and collaboration agreement with CC-Pharming Ltd. The company is headquartered in Bryan, Texas.

Stock Peers

ARGX

19.43+2.42%

argenx SE$822.13 REGN

-7.01-0.97%

Regeneron Pharmaceuticals, Inc.$712.87 UTHR

-3.75-0.65%

United Therapeutics Corporation$575.79 MDGL

21.02+4.05%

Madrigal Pharmaceuticals, Inc.$539.89 VRTX

-2.65-0.58%

Vertex Pharmaceuticals Incorporated$450.41 PRAX

-1.32-0.38%

Praxis Precision Medicines, Inc.$345.52 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 KRYS

3.72+1.19%

Krystal Biotech, Inc.$316.30 ALNY

1.97+0.68%

Alnylam Pharmaceuticals, Inc.$293.45 ASND

1.91+0.78%

Ascendis Pharma A/S$245.49

Frequently Asked Questions

What is the current iBio, Inc. (IBIO) stock price?

iBio, Inc. (NASDAQ: IBIO) stock price is $1.56 in the last trading session. During the trading session, IBIO stock reached the peak price of $1.57 while $1.51 was the lowest point it dropped to. The percentage change in IBIO stock occurred in the recent session was 0.65% while the dollar amount for the price change in IBIO stock was $0.01.

IBIO's industry and sector of operation?

The NASDAQ listed IBIO is part of Biotechnology industry that operates in the broader Healthcare sector. iBio, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of IBIO?

Dr. Melissa Berquist Ph.D.
Vice President and Head of Vaccines & Animal Health
Mr. Thomas F. Isett III
Chief Executive Officer, Pres & Executive Director
Mr. Robert Matthew Lutz
Chief Financial & Bus. Officer
Mr. Felipe Duran
Chief Financial Officer
Ms. Lisa Middlebrook
Chief HR Officer
Mr. Randy Joe Maddux
Strategic Advisor
Mr. Robert B. Kay
Interim Sec. & Interim Treasurer
Dr. Nick DeLong Ph.D.
Vice President of Corporation Devel.
Dr. Martin B. Brenner D.V.M., Ph.D.
Interim Chief Executive Officer & Chief Scientific Officer
Mike Jenkins
Vice President of Operations
Mr. Marc Banjak J.D.
Gen. Counsel
Carlos Picosse
Chief Executive Officer of IBio Brazil

How IBIO did perform over past 52-week?

IBIO's closing price is 178.57% higher than its 52-week low of $0.56 where as its distance from 52-week high of $3.82 is -59.16%.

How many employees does IBIO have?

Number of IBIO employees currently stands at 16.

Link for IBIO official website?

Official Website of IBIO is: https://www.ibioinc.com

How do I contact IBIO?

IBIO could be contacted at phone 979 446 0027 and can also be accessed through its website. IBIO operates from 8800 HSC Parkway, Bryan, TX 77807, United States.

How many shares of IBIO are traded daily?

IBIO stock volume for the day was 699.41K shares. The average number of IBIO shares traded daily for last 3 months was 1.02M.

What is the market cap of IBIO currently?

The market value of IBIO currently stands at $24.63M with its latest stock price at $1.56 and 15.79M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	16
Beta	1.36
Sales or Revenue	$400.00K
5Y Sales Change%	-0.989%
Fiscal Year Ends	June
Sector	Healthcare
Industry	Biotechnology

Employees	16
Beta	1.36
Sales or Revenue	$400.00K
5Y Sales Change%	-0.989%
Fiscal Year Ends	June
Sector	Healthcare
Industry	Biotechnology

IBIO Company Profile and Key Details

iBio

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Dividend & Fair Value

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Company Overview

Price Forecast & Outlook

Key Takeaways

Valuation Metrics